Names | |
---|---|
IUPAC name
[3-(2-Dimethylaminoethyl)-1H-indol-4-yl] dihydrogen phosphate
|
|
Identifiers | |
3D model (Jmol)
|
|
273158 | |
ChEBI | |
ChemSpider | |
ECHA InfoCard | 100.007.542 |
EC Number | 208-294-4 |
KEGG | |
MeSH | Psilocybine |
PubChem CID
|
|
RTECS number | NM3150000 |
|
|
|
|
Pharmacology | |
Low | |
Oral, intravenous | |
Pharmacokinetics: | |
Hepatic | |
oral: 163±64 min intravenous: 74.1±19.6 min |
|
Renal | |
Legal status |
|
Properties | |
C12H17N2O4P | |
Molar mass | 284.25 g·mol−1 |
Melting point | 220–228 °C (428–442 °F) |
soluble | |
Solubility | soluble in methanol slightly soluble in ethanol negligible in chloroform, benzene |
Hazards | |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
285 mg/kg (mouse, i.v.) 280 mg/kg (rat, i.v.) 12.5 mg/kg (rabbit, i.v.) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
Psilocybin (/ˌsɪləˈsaɪbɪn/ SIL-ə-SY-bin) is a naturally occurring psychedelic compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms. The most potent are members of the genus Psilocybe, such as P. azurescens, P. semilanceata, and P. cyanescens, but psilocybin has also been isolated from about a dozen other genera. As a prodrug, psilocybin is quickly converted by the body to psilocin, which has mind-altering effects similar, in some aspects, to those of LSD, mescaline, and DMT. In general, the effects include euphoria, visual and mental hallucinations, changes in perception, a distorted sense of time, and spiritual experiences, and can include possible adverse reactions such as nausea and panic attacks.